A Novel Approach to Deliver Therapeutic Extracellular Vesicles Directly into the Mouse Kidney via Its Arterial Blood Supply
Autor: | Waldo Concepcion, Mehdi Razavi, Jing Wang, Mujib Ullah, Daniel D. Liu, Sravanthi Rai, Avnesh S. Thakor, Jeff Choi |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Pathology medicine.medical_specialty Stromal cell medicine.medical_treatment locoregional delivery Inflammation Kidney Extracellular vesicles Targeted therapy Extracellular Vesicles Mice 03 medical and health sciences 0302 clinical medicine Technical Note medicine Animals Humans lcsh:QH301-705.5 business.industry Regeneration (biology) Mesenchymal stem cell Acute kidney injury microsurgery General Medicine Acute Kidney Injury targeted therapy medicine.disease Disease Models Animal 030104 developmental biology medicine.anatomical_structure lcsh:Biology (General) 030220 oncology & carcinogenesis Female intra-arterial delivery medicine.symptom mesenchymal stromal cells business |
Zdroj: | Cells Cells, Vol 9, Iss 937, p 937 (2020) |
ISSN: | 2073-4409 |
Popis: | Diseases of the kidney contribute a significant morbidity and mortality burden on society. Localized delivery of therapeutics directly into the kidney, via its arterial blood supply, has the potential to enhance their therapeutic efficacy while limiting side effects associated with conventional systemic delivery. Targeted delivery in humans is feasible given that we can access the renal arterial blood supply using minimally invasive endovascular techniques and imaging guidance. However, there is currently no described way to reproduce or mimic this approach in a small animal model. Here, we develop in mice a reproducible microsurgical technique for the delivery of therapeutics directly into each kidney, via its arterial blood supply. Using our technique, intra-arterially (IA) injected tattoo dye homogenously stained both kidneys, without staining any other organ. Survival studies showed no resulting mortality or iatrogenic kidney injury. We demonstrate the therapeutic potential of our technique in a mouse model of cisplatin-induced acute kidney injury (AKI). IA injection of mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) successfully reversed AKI, with reduced physiological and molecular markers of kidney injury, attenuated inflammation, and restoration of proliferation and regeneration markers. This reproducible delivery technique will allow for further pre-clinical translational studies investigating other therapies for the treatment of renal pathologies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |